Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
BVS Bioventus Inc
- Stocks
- Healthcare
- NASDAQ: BVS
Price (delayed)
$6.79
Market cap
$557.76M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.48
Enterprise value
$880.89M
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations
Highlights
The gross profit has grown by 12% YoY
The revenue is up by 9% year-on-year
The company's net income fell by 44% YoY but it rose by 6% QoQ
Bioventus's EPS has decreased by 37% YoY but it has increased by 8% from the previous quarter
Bioventus's equity has decreased by 14% YoY
The quick ratio has declined by 7% year-on-year
Key stats
What are the main financial stats of BVS
Market
Valuations
Earnings
Shares outstanding
82.14M
Market cap
$557.76M
Enterprise value
$880.89M
Price to earnings (P/E)
N/A
Price to book (P/B)
3.76
Price to sales (P/S)
0.79
EV/EBIT
N/A
EV/EBITDA
18.47
EV/Sales
1.55
Revenue
$567.7M
Gross profit
$382.9M
Operating income
-$46.34M
Net income
-$31.61M
EBIT
-$1.94M
EBITDA
$47.69M
Free cash flow
$23.93M
Per share
Balance sheet
Liquidity
EPS
-$0.48
EPS diluted
-$0.48
Free cash flow per share
$0.36
Book value per share
$1.81
Revenue per share
$8.6
TBVPS
$4.37
Total assets
$691.41M
Total liabilities
$505.94M
Debt
$345.93M
Equity
$148.14M
Working capital
$74.62M
Debt to equity
2.34
Current ratio
1.43
Quick ratio
0.81
Net debt/EBITDA
6.78
Margins
Efficiency
Dividend
EBITDA margin
8.4%
Gross margin
67.4%
Net margin
-5.6%
Operating margin
-8.2%
Return on assets
-4.2%
Return on equity
-21.2%
Return on invested capital
-0.4%
Return on capital employed
-0.4%
Return on sales
-0.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
BVS stock price
How has the Bioventus stock price performed over time
Intraday
3.82%
1 week
1.65%
1 month
-12.72%
1 year
2.41%
YTD
-35.33%
QTD
-25.79%
Financial performance
How have Bioventus's revenue and profit performed over time
Revenue
$567.7M
Gross profit
$382.9M
Operating income
-$46.34M
Net income
-$31.61M
Gross margin
67.4%
Net margin
-5.6%
The operating income has plunged by 80% YoY but it has grown by 2.9% from the previous quarter
Bioventus's operating margin has shrunk by 67% YoY
The company's net income fell by 44% YoY but it rose by 6% QoQ
BVS's net margin is down by 33% YoY but it is up by 5% QoQ
Price vs fundamentals
How does BVS's price correlate with its fundamentals
Growth
What is Bioventus's growth rate over time
Valuation
What is Bioventus stock price valuation
P/E
N/A
P/B
3.76
P/S
0.79
EV/EBIT
N/A
EV/EBITDA
18.47
EV/Sales
1.55
Bioventus's EPS has decreased by 37% YoY but it has increased by 8% from the previous quarter
BVS's price to book (P/B) is 25% less than its last 4 quarters average of 5.0 but 18% more than its 5-year quarterly average of 3.2
Bioventus's equity has decreased by 14% YoY
BVS's P/S is 28% below its last 4 quarters average of 1.1 and 21% below its 5-year quarterly average of 1.0
The revenue is up by 9% year-on-year
Efficiency
How efficient is Bioventus business performance
The return on invested capital has dropped by 110% year-on-year
Bioventus's ROS has plunged by 108% YoY
The ROE has dropped by 70% year-on-year but it is up by 2.3% since the previous quarter
The return on assets has dropped by 56% year-on-year but it has increased by 4.5% since the previous quarter
Dividends
What is BVS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for BVS.
Financial health
How did Bioventus financials performed over time
Bioventus's total assets is 37% more than its total liabilities
Bioventus's total assets has decreased by 13% YoY and by 5% from the previous quarter
Bioventus's total liabilities has decreased by 12% YoY and by 7% QoQ
BVS's debt is 134% higher than its equity
Bioventus's equity has decreased by 14% YoY
BVS's debt is down by 12% YoY but it is up by 3.1% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.